Allergan Debt to Equity Ratio:
0.4056 for Dec. 31, 2012Allergan Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.4056 |
| Dec. 31, 2012 | 0.2675 |
| Sept. 30, 2012 | 0.2794 |
| June 30, 2012 | 0.2863 |
| March 31, 2012 | 0.2936 |
| Dec. 31, 2011 | 0.3012 |
| Sept. 30, 2011 | 0.3124 |
| June 30, 2011 | 0.3196 |
| March 31, 2011 | 0.4552 |
| Dec. 31, 2010 | 0.4634 |
| Sept. 30, 2010 | 0.4934 |
| June 30, 2010 | 0.301 |
| March 31, 2010 | 0.3072 |
| Dec. 31, 2009 | 0.313 |
| Sept. 30, 2009 | 0.3319 |
| June 30, 2009 | 0.3434 |
| March 31, 2009 | 0.3589 |
| Dec. 31, 2008 | 0.3888 |
| Sept. 30, 2008 | 0.4003 |
| June 30, 2008 | 0.4055 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
AGN Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Valeant Pharmaceuticals International | 2.960 |
| Dr. Reddy Laboratories | 0.5514 |
| AVANIR Pharmaceuticals | 1.107 |
AGN Debt to Equity Ratio Rankings
| Overall |
63rd percentile 2754 of 7593 |
| Sector |
40th percentile 388 of 650 in Healthcare |
| Industry |
40th percentile 39 of 65 in Drug Manufacturers - Specialty & Generic |
AGN Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.2675 | Dec 2012 |
| Maximum | 0.4934 | Sep 2010 |
| Average | 0.3514 |
